Post-Stroke Medication Relay
REMEDIPA
1 other identifier
observational
54
1 country
1
Brief Summary
Prior to discharge from hospital and return home, patients managed for ischemic stroke will receive a pharmaceutical interview to discuss their discharge prescription (indication, method of administration, precautions, and possible side effects). Improvements in the use of medications in the community and in hospital follow-up. Telephone interviews or teleconsultations will make it possible to assess the patient's knowledge of his or her treatment and to re-explain it if necessary to improve patient compliance with treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedStudy Start
First participant enrolled
March 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2022
CompletedMarch 18, 2026
March 1, 2026
1.1 years
January 4, 2021
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Assess the value of a telephone interview / teleconsultation after discharge from hospital following an ischemic stroke
The value of a telephone interview / teleconsultation will be assess by comparison of treatment knowledge between the first questionnaire at one week and the second questionnaire at two months after the pharmaceutical interview and hospital discharge. Statistical evaluation by comparative tests at one week versus two months. Assessment will focus on treatment knowledge (score between 0 and 3), adherence (score between 0 and 6) and adverse events (score between 0 and 3)
1 week
Assess the value of a telephone interview / teleconsultation after discharge from hospital following an ischemic stroke
The value of a telephone interview / teleconsultation will be assess by comparison of treatment knowledge between the first questionnaire at one week and the second questionnaire at two months after the pharmaceutical interview and hospital discharge. Statistical evaluation by comparative tests at one week versus two months. Assessment will focus on treatment knowledge (score between 0 and 3), adherence (score between 0 and 6) and adverse events (score between 0 and 3)
2 months
Interventions
Selection of patients for a discharge interview in the stroke unit with collection of non-opposition and scheduling of telephone interviews or by teleconsultations at one week and then at two months after hospitalization. Data collection through interviews using a telephone questionnaire (or by teleconsultation) one week and then at two months after discharge. Elements on knowledge of treatment, dietary measures and warning signs and recurrence of stroke will be collected and re-explained if necessary.
Eligibility Criteria
Adults patients managed in stroke unit following ischemic stroke who benefiting from a direct return at home.
You may qualify if:
- Adult patients managed in stroke unit following ischemic stroke
- Benefiting from a direct return home
- Non-opposition to participation
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Neurologie Vasculaire, Unité 201 Hôpital Neurologique Pierre Wertheimer, HCL
Bron, 69677, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2021
First Posted
January 6, 2021
Study Start
March 11, 2021
Primary Completion
April 27, 2022
Study Completion
April 27, 2022
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share